nadolol has been researched along with dolutegravir in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Álvarez, M; Cheng, X; De Clercq, E; Gao, P; Liu, X; Luczkowiak, J; Menéndez-Arias, L; Pannecouque, C; Song, S; Sun, L; Zhan, P | 1 |
1 other study(ies) available for nadolol and dolutegravir
Article | Year |
---|---|
Design, synthesis and biological evaluation of 3-hydroxyquinazoline-2,4(1H,3H)-diones as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and integrase.
Topics: Anti-HIV Agents; Caco-2 Cells; Cell Line; Cell Membrane Permeability; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; HIV Integrase; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Models, Molecular; Molecular Structure; Quinazolinones; Ribonuclease H, Human Immunodeficiency Virus; Structure-Activity Relationship | 2019 |